Depends if the buy offer is real or not. If it is, $65 might be a low ball. I don't think the board would reject an offer that gives them immediate 20% profit, unlike how Illumina passed on their offer from Roche. Life directors are too greedy to let that one pass. If it's just company hype, I'll see you all back at $55 or lower.....The market could punish this stock for a head fake like that. But for now, just going to hold on to my shares and Prozac out.
I think anyone that says for sure that they know what's coming, is fantasizing.